M. and Müller, B.W. (1998), The effect of oil components and homogenization condition on the physicochemical properties and stability of parenteral fat emulsions, Int. J. Pharm., 163 (s1–s2), 81–89. doi:10.1016/S0378‐5173(97)00369‐4
45 Jumaa, M. and Müller, B.W. (1999), Physicochemical properties of chitosan‐lipid emulsions and their stability during the autoclaving process, Int. J. Pharm., 183 (2), 175–184. doi:10.1016/s0378‐5173(99)00086‐1
46 Jumaa, M. and Müller, B.W. (2002), Parenteral emulsions stabilized with a mixture of phospholipids and PEG‐660‐12‐hydroxy‐stearate: evaluation of accelerated and long‐term stability, Eur. J. Pharm. Biopharm., 54 (2), 207–212. doi:10.1016/s0939‐6411(02)00057‐7
47 Kador, P.F. and Kinoshita, J.H. (1978), Phospholipid effects on the rat lens transport systems, Exp. Eye Res., 26 (6), 657–665. doi:10.1016/0014‐4835(78)90100‐8
48 Kim, T.W., Chung, H., Kwon, I.C. et al. (2005), Airway gene transfer using cationic emulsion as a mucosal gene carrier, J. Gen. Med., 7 (6), 749–758. doi:10.1002/jgm.711
49 Kim, Y.J., Kim, T.W., Chung, H. et al. (2003), The effects of serum on the stability and the transfection activity of the cationic lipid emulsion with various oils, Int. J. Pharm., 252 (1–2), 241–252. doi:10.1016/s0378‐5173(02)00676‐2
50 Lan, Q., Yang, F., Zhang, S. et al. (2007), Synergistic effect of silica nanoparticle and cetyltrimethyl ammonium bromide on the stabilization of O/W emulsions, Colloids Surf. A Physicochem. Eng. Aspects, 302 (1–3), 126–135. doi:10.1016/j.colsurfa.2007.02.010
51 Lance, M.R., Washington, C., and Davis, S.S. (1995), Structure and toxicity of amphotericin B/triglyceride emulsion formulations, J. Antimicrob. Chemother., 36 (1), 119–128. doi:10.1093/jac/36.1.119
52 Landfester, K. (2006), Synthesis of colloidal particles in miniemulsions, Annu. Rev. Mater. Res., 36, 231–279. doi:10.1146/annurev.matsci.36.032905.091025
53 Lee, V.H.L. and Robinson, J.R. (1986), Review: topical ocular drug delivery: recent developments and future challenges, J. Ocul. Pharmacol., 2 (1), 67–108. doi:10.1089/jop.1986.2.67
54 Liang, H., Brignole‐Baudouin, F., Rabinovich‐Guilatt, L. et al. (2008), Reduction of quaternary ammonium‐induced ocular surface toxicity by emulsions: an in vivo study in rabbits, Mol. Vis., 14, 204–216. http://www.molvis.org/molvis/v14/a26
55 Liu, Y., Mounkes, L.C., Liggitt, H.D. et al. (1997), Factors influencing the efficiency of cationic liposome‐mediated intravenous gene delivery, Nat. Biotechnol., 15 (2), 167–173. doi:10.1038/nbt0297‐167
56 Lundberg, B.B., Griffiths, G., and Hansen, H.J. (1999), Conjugation of an anti‐B‐cell lymphoma monoclonal antibody, LL2, to long‐circulating drug‐carrier lipid emulsions, J. Pharm. Pharmacol., 51, 1099–1105. doi:10.1211/0022357991776787
57 Lundberg, B.B., Griffiths, G., and Hansen, H.J. (2004), Cellular association and cytotoxicity of anti‐CD74‐targeted lipid drug‐carriers in B lymphoma cells, J. Control. Release, 94 (1), 155–161. doi:10.1016/j.jconrel.2003.09.016
58 Memisoglu, E., Bochot, A., Sen, M. et al. (2002), Amphiphilic β‐cyclodextrins modified on the primary face: synthesis, characterization and evaluation of their potential as novel excipients in the preparation of nanocapsules, J. Pharm. Sci., 91 (5), 1214–1224. doi:10.1002/jps.10105
59 Midmore, B.R. (1998), Synergy between silica and polyoxyethylene surfactants in the formation of o/w emulsions, Colloids Surf. A Physicochem. Eng. Aspects, 145 (1–3), 133–143. doi:10.1016/S0927‐7757(98)00577‐9
60 Montgomery, D.C. (2013), Design and Analysis of Experiments, 8th ed., Wiley, Hoboken, NJ; Chapter 1 (p. 3,19), Chapter 11 (p. 501), Chapter 14 (p. 605).
61 Moolman, F.S., Rolfes, H., van der Merwe, S.W. et al. (2004), Optimization of perfluorocarbon emulsion properties for enhancing oxygen mass transfer in a bio‐artificial liver support system, Biochem. Eng. J., 19 (3), 237–250. doi:10.1016/j.bej.2004.02.003
62 Motwani, S.K., Copra, S. Talegaonkar, S. et al. (2008), Chitosan‐sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimization and in vitro characterization, J. Pharm. Biopharm., 68 (3), 513–525. doi:10.1016/j.ejpb.2007.09.009
63 Muchtar, S. and Benita, S. (1994), Emulsions as drug carriers for ophthalmic use, Colloid Surf. A Physicochem. Eng. Aspects, 91 (3), 181–190. doi:10.1016/0927‐7757(94)02882‐6
64 Müllar, R.H. (1990), Colloidal Carriers for Controlled Drug Delivery and Targeting: Modification, Characterization and In Vivo Distribution, Wiss Verl‐Ges, Stuttgart, Germany.
65 Müller, R.H. and Schmidt, S. (2002). SolEmuls technology for i.v. emulsions of poorly soluble drugs: amphotericin B, in: Fourth World Meeting on Pharamceutics, Biopharmaceutics and Pharmaceutical Technology, Florence, pp. 1451–1452.
66 Nakajima, M., Nabetani, H., Ichikawa, S. et al. (2003), Functional emulsions, US Patent 6538019.
67 Naskar, M.K., Patra, A., and Chatterjee, M. (2006), Understanding the role of surfactants on the preparation of ZnS nanocrystals, J. Colloid Interface Sci., 297 (1), 271–275. doi:10.1016/j.jcis.2005.10.057
68 Negi, P., Singh, B., Sharma, G. et al. (2015), Biocompatible lidocaine and prilocaine loaded‐nanosized emulsion system for enhanced percutaneous absorption: QbD‐based optimisation, dermatokinetics and in vivo evaluation, J. Microencapsul., 32 (5), 419–431. doi:10.3109/02652048.2015.104651
69 Nobs, L., Buchegger, F., Gurny, R. et al. (2004), Current methods for attaching targeting ligands to liposomes and nanoparticles, J. Pharm. Sci., 93 (8), 1980–1992. doi:10.1002/jps.20098
70 Ogawa, S., Decker, E.A., and McClements, D.J. (2003), Production and characterization of o/w emulsions containing cationic droplets stabilized by lecithin‐chitosan membranes, J. Agric. Food Chem., 51 (9), 2606–2812. doi:10.1021/jf020590f
71 Orloff, J.J. (2011), The promise and threat of quality risk management, Pharm. Technol., 35 (2), 38–40.
72 Pickering, S.U. (1907), Emulsions, J. Chem. Soc., 91, 2001–2021. doi:10.1039/CT9079102001
73 Pongcharoenkiat, N., Narsimhan, G., Lyons, R.T. et al. (2002), The effect of surface charge and partition coefficient on the chemical stability of solutes in o/w emulsions, J. Pharm. Sci., 91 (2), 559–570. doi:10.1002/jps.10064
74 Puri, D., Khatik, G.L., and Tamilvanan, S. (2019), Studies on olive‐and silicone‐oils‐based Janus macroemulsions containing ginger to manage primary dysmenorrheal pain, Mater. Sci. Eng. C Mater. Biol. Appl., 100, 276–285. doi:10.1016/j.msec.2019.01.137
75 Q8(R2) (2009), ICH harmonized tripartite guideline for pharmaceutical development, current step 4 version, (Accessed on August 1, 2019).
76 Simberg, D., Weisman, S., Talmon, Y. et al. (2003), The role of organ vascularization and lipoplex‐serum initial contact in intravenous murine lipofection, J. Biol. Chem., 278, 39858–39865. doi:10.1074/jbc.M302232200
77 Simovic, S. and Prestidge, C.A. (2003), Adsorption of hydrophobic silica nanoparticles at the PDMS droplet‐water interface, Langmuir, 19, 8364–8370. doi:10.1021/la0347197
78 Simovic, S. and Prestidge, C.A. (2007), Nanoparticle layers controlling drug release from emulsions, Eur. J. Pharm. Biopharm., 67 (1), 39–47. doi:10.1016/j.ejpb.2007.01.011
79 Simovic, S. and Prestidge, C.A. (2008), Colloidosomes from controlled interaction of submicrometer triglyseride droplets and hydrophilic silica nanoparticles, Langmuir, 24, 7132–7137. doi:10.1021/la800862v
80 Song, Y.K., Liu, D., and Maruyama, K.Z. (1996), Antibody mediated lung targeting of long‐circulating emulsions, PDA J. Pharm. Sci. Technol., 50 (6), 372–377.
81 Sonne, M.R. (2015), Tocopherol compositions for delivery of biologically active agents, in: USPTO Patent full‐text and image database no. 6,193,985, Dumex, Copenhagen, pp. 1–21.
82 Solans, C., Izquierdo, P., Nolla, J. et al. (2005), Nano‐emulsions, Curr. Opin. Colloid